Finasteride 1mg tablets

Страна: Велика Британія

мова: англійська

Джерело: MHRA (Medicines & Healthcare Products Regulatory Agency)

Активний інгредієнт:

Finasteride

Доступна з:

Ennogen Healthcare Ltd

Код атс:

D11AX10

ІПН (Міжнародна Ім'я):

Finasteride

Дозування:

1mg

Фармацевтична форма:

Oral tablet

Адміністрація маршрут:

Oral

Клас:

No Controlled Drug Status

Тип рецепту:

Invalid to prescribe in NHS primary care

Огляд продуктів:

BNF: 13090000

Характеристики продукта

SUMMARY OF PRODUCT CHARACTERISTICS
1
NAME OF THE MEDICINAL PRODUCT
Finasteride 1mg Film-coated Tablets
2
QUALITATIVE AND QUANTITATIVE COMPOSITION
Each tablet contains 1mg of finasteride.
Excipient(s):
Each tablet also contains 44mg of lactose.
For a full list of excipients, see section 6.1.
3
PHARMACEUTICAL FORM
Film-coated tablet
Light brown, round biconvex film-coated tablet debossed with “FIN”
on one side and
“1” on reverse.
4
CLINICAL PARTICULARS
4.1
THERAPEUTIC INDICATIONS
Early stages of androgenetic alopecia in men, Finasteride 1mg
Film-coated Tablets
stabilizes the process of androgenetic alopecia in men 18-41 years of
age. Efficacy in
bitemporal recession and end-stage hair loss has not been established.
4.2
POSOLOGY AND METHOD OF ADMINISTRATION
Route of administration: oral use.
Men: 1mg once daily with or without food for 3-6 months before any
noticeable
difference is
evident. There is no evidence that higher doses of finasteride result
in
increased efficacy.
Efficacy and duration should be continuously assessed by the treating
physician.
Generally, continued treatment for 3-6 months is required before
stabilisation of hair
loss can be expected. Continued treatment is advised to sustain
benefit. If treatment
is stopped, the beneficial effects begin to reverse after about 6
months, and return to
baseline after 9-12months.
No data are available on the concomitant use of Finasteride with
topical minoxidil for
the treatment of male hair loss.
_Dosage in the elderly. _ _No dosage adjustment is required in the
elderly (see section _
_5.2)._
_Dosage in renal insufficiency._ _ Dosage adjustments are not
necessary (see section _
_5.2)_
_Dosage in hepatic insufficiency._ There are no data available for the
use of finasteride
in patients with hepatic insufficiency (see section 4.4 and 5.2).
_ _
_Children: _ This medicine should not be administered to children (see
section 4.3).
Finasteride 1 mg Film-coated Tablets is contraindicated in children
(see section 4.3)
4.3
CONTRAINDICATIONS
Contra-indicated
in
w